DUBLIN--(BUSINESS WIRE)--Dublin - Research and Markets (http://www.researchandmarkets.com/research/5a7516c4/mozambique_pharmac) has announced the addition of the "Mozambique Pharmaceuticals and Healthcare Report Q2 2012" report to their offering.
Business Monitor International's Mozambique Pharmaceuticals and Healthcare Report provides industry professionals and strategists, corporate analysts, pharmaceutical associations, government departments and regulatory bodies with independent forecasts and competitive intelligence on Mozambique's pharmaceuticals and healthcare industry.
BMI View:
Mozambique's pharmaceutical market is typical of developing markets, with a poor regulatory framework, dependence upon donations by aid and government agencies, low spending on healthcare per capita and with health centres and hospitals understaffed by individuals that often lack sufficient training. Current market opportunities are limited to the sale of low-margin, generic drugs, although plans for Mozambique to build its first domestic pharmaceutical production plant - in a deal partly funded by Brazil - could help attract additional international investment once it begins production later in 2012. Mozambique is burdened by both communicable and non-communicable diseases.
Key Trends & Developments
- Health Minister Alexandre Manguele announced in January 2012 that Mozambique is scheduled to produce its first antiretroviral drugs by July 2012. Mozambique will produce the drugs in a facility constructed thanks to Brazil funding.
- Mozambique, Brazil and the US signed an agreement in January 2012 which will see the three countries collaborating on food security, agriculture and health. Part of this agreement concerns the distribution of essential drugs, and the training of Mozambican healthcare professionals by US and Brazilian doctors.
- In January 2012, Mozambique was affected by two tropical storms, these saw part of its main national highway cut off and by 24 January 2012, the death toll stood at 18. The government has expressed its concern at the risk of a cholera outbreak and has distributed chlorine tablets to purify water.
Key Topics Covered By "Mozambique Pharmaceuticals and Healthcare Report Q2 2012":
- BMI Industry View
- Pharmaceutical and Healthcare Risk/Reward Ratings
- Pharmaceutical Market Forecast
- Healthcare Market Forecast
- Competitive Landscape
- Glossary
- BMI Methodology
For more information, including full table of contents, please visit http://www.researchandmarkets.com/research/5a7516c4/mozambique_pharmac